Garner Health
PrivateLast Round
Series E
May 28, 2026
Est. Valuation
$2.74B
Total Funding Raised
$280M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Garner Health operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series E round in May 2026.
Garner Health is a health technology company that provides a platform for employers to help their employees find high-quality, cost-effective healthcare providers using data analytics and financial incentives.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Subscription SaaS, Data as a Service, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Garner Health Comparables
Compare Garner Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcarent | 88% | |
| Included Health | 83% | |
| Pager | 81% |
For institutional investors. Book with your work email.
Garner Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | May 28, 2026 | ||||
| Series D | Feb 10, 2026 | ||||
| Series B | Dec 14, 2021 | ||||
| Strategic | Jul 27, 2021 | ||||
| Series A | Feb 3, 2021 | ||||
Seed | Jan 14, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Garner Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maverick Capital | Series D, Series A |
| Plus Capital | Series D |
| Maverick Ventures | Series D, Series A, Series B |
| Kaiser Permanente Ventures | Series D, Series E |
| Founders Fund | Series E, Series B, Series A |
| Thrive Capital | Series A, Series E, Series B, Seed |
| Sequoia Capital | Series E, Seed, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 2, 2026
Open roles increased to 91, double the trailing average.
- Oct 19, 2026
Open roles increased to 86, 4.5x the trailing average.
For institutional investors. Book with your work email.
Garner Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Garner Health's valuation, stock price, and market status.
Is Garner Health a public or private company?
Garner Health is a private company.
What is the current stock price of Garner Health?
Garner Health is a private company, so its shares have no public market price. Caplight tracks Garner Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Garner Health worth (valuation)?
Garner Health's valuation is estimated at $2.7B based on funding round data.
Can I buy Garner Health stock?
Garner Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Garner Health's last funding round?
Garner Health's most recent funding round was Series E on May 28, 2026.
Who are the main investors in Garner Health?
Key investors in Garner Health include Founders Fund, Thrive Capital, Optum Ventures, Index Ventures, Redpoint Ventures.
Will Garner Health IPO soon?
No public IPO plans have been announced for Garner Health.
How can I track Garner Health secondary market activity?
Caplight tracks bids, offers, and trades in Garner Health's shares on secondary markets.